Colefax Group (CFX)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 1,345.00 |
|---|---|
| 52-week range | 875.47 – 1,512.16 |
| Return, 1 month / 3 months | −0.4% / −5.4% |
| Return, 1 year / 3 years | +51.9% / +84.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 21.9% |
| Worst drawdown (1 year) | -10.3% |
| Average daily value traded | 3.25M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Colefax Group designs and distributes furnishing fabrics, wallpapers and related home furnishings. Its brands, including Colefax and Fowler, Jane Churchill and Manuel Canovas, serve interior designers, decorators and retail customers. The company is based in London and operates through fabric and wallpaper divisions alongside a decorating business, supplying both residential and contract markets in Britain and overseas.
The shares are listed on the London Exchange in UK under the code CFX, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Colefax Group (CFX) trades on the London Exchange in UK. It last closed at GBX 1,345.00 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 642 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.9% and over the last three months it fell 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.2% | ||
| From 52-week high | -8.9% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.4% | ||
| 6-month return | 14.3% | ||
| 12-month return, skipping the last month | 52.5% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.3% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.25M GBX | ||
| Zero-volume days | 6.7% | ||
| Income | 20 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −0.4% |
| 3 months | −5.4% |
| 6 months | +14.3% |
| 1 year | +51.9% |
| 3 years | +84.0% |
| 5 years | +115.6% |
Signals
| 50-day / 200-day average | 1,382.69 / 1,266.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 40.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0330 |
| 12 Mar 2026 | GBP 0.0300 |
| 11 Sep 2025 | GBP 0.0310 |
| 6 Mar 2025 | GBP 0.0280 |
| 12 Sep 2024 | GBP 0.0290 |
| 7 Mar 2024 | GBP 0.0270 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.